emtricitabine - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
TENOFOVIR / EMTRICITABINE SANDOZ 301/200 tenofovir disoproxil succinate / emtricitabine 301 mg/200 mg film-coated tablet bottle AUST R: 326237Active ingredients:
emtricitabine
tenofovir disoproxil succinate
Dosage form: Tablet, film coated
Sponsor: Sandoz Pty Ltd
Phone: 1800 726 369
|
From 03 Nov 2023 to 14 Oct 2024
|
Shortage status: Current
Availability: Unavailable
Reason: Manufacturing
Management action: Alternative generic brands are available.
|
TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 tenofovir disoproxil maleate 300 mg and emtricitabine 200 mg film coated tablet bottle AUST R: 265834Active ingredients:
emtricitabine
tenofovir disoproxil maleate
Dosage form: Tablet, film coated
Sponsor: Alphapharm Pty Ltd
Phone: 1800274276
|
From 13 Feb 2024 to 10 Apr 2024
|
Shortage status: Current
Availability: Limited Availability
Reason: Manufacturing
Management action: Alternative generic brands are available.
|
TENOFOVIR EMT GH tenofovir disoproxil phosphate and emtricitabine 291mg/200mg film coated tablets AUST R: 269196Active ingredients:
emtricitabine
tenofovir disoproxil phosphate
Dosage form: Tablet, film coated
Sponsor: Lupin Australia Pty Limited
Phone: 03 9809 7900
|
Deletion from market:
01 Apr 2024
|
Shortage status: To be discontinued
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
|